burosumab

Spain

Drugs containing this active substance

  • CRYSVITA 10 MG SOLUTION FOR INJECTION

    It is used to treat X-linked hypophosphatemia (XLH) in children, adolescents, and adults, as well as tumor-induced osteomalacia (TIO) in patients who cannot undergo tumor removal.

    Form: solution for injection

    Active substance Dosage
    burosumab 10 mg

    ATC: M05B M05BX M05BX05

    Manufacturer: Kyowa Kirin Holdings B.V.

  • It is used to treat X-linked hypophosphatemia (XLH) in children, adolescents, and adults, as well as tumor-induced osteomalacia (TIO) when the tumor cannot be removed or located, also in children, adolescents, and adults.

    Form: solution for injection

    Active substance Dosage
    burosumab 20 mg

    ATC: M05B M05BX M05BX05

    Manufacturer: Kyowa Kirin Holdings B.V.

  • It is used to treat X-linked hypophosphatemia (XLH) in children, adolescents, and adults, as well as tumor-induced osteomalacia (TIO) when the tumor cannot be surgically removed or located, also in children, adolescents, and adults.

    Form: solution for injection

    Active substance Dosage
    burosumab 30 mg

    ATC: M05B M05BX M05BX05

    Manufacturer: Kyowa Kirin Holdings B.V.